The AI model demonstrated an AUC of 0.71, which was significantly higher than the AUC of 0.54 reached using the tumor size-based model An artificial intelligence (AI)-based model for analyzing images ...
According to Tang, this independence suggests that each biomarker provides unique prognostic information, making both valuable for understanding patient outcomes. Building on these findings, the ...
Data from 1,052 patients with aRCC treated on the CheckMate-214 phase III randomized trial with first-line nivolumab + ipilimumab or sunitinib were analyzed after minimum 5 years of follow-up. The end ...
An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict which kidney cancer patients will benefit from anti-angiogenic therapy, a ...
Cancer cell-derived small extracellular vesicles (sEVs) can travel from distant tumors through the bloodstream and kidneys ...
Kidney cancer treatment has shifted towards active surveillance and minimally invasive surgeries, improving patient outcomes and preserving kidney function. Robotic surgical techniques, including ...
The experimental drug is an ultrasensitive version of CAR-T therapies, which have already revolutionized the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results